Rhone Ma Holdings Berhad (KLSE: RHONEMA)
Health Care · Pharmaceuticals · MY
RM0.68
-1.45% today · +1.5% 1Y
Rhone Ma Holdings Berhad (KLSE: RHONEMA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $37.26M.
Over the last twelve months the share price has gained 1.5%, trading between 0.62 and 0.73.
Tweenvest scores Rhone Ma Holdings Berhad across four factors: quality 80/100, value 85/100, growth 49/100, dividend 76/100. Its strongest factor is value.
RHONEMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $37.26M
- Revenue (TTM)
- $56.04M
- P/E
- 12.29
- EPS
- 0.06
- Dividend yield
- 3.68%
- Beta (5Y)
- 0.16
- 52-week high
- RM0.73
- 52-week low
- RM0.62
- Avg volume (3M)
- —
- Shares outstanding
- 221.30M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.75 | +0.19% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.56 | +0.66% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.